Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity of Roma La Sapienza
About this trial
This randomized clinical trial evaluates the efficacy of a microRepair ABX mouthwash mousse compared to 0.20% chlorhexidine in promoting wound healing following tooth extraction. The study monitors clinical parameters such as pain, swelling, and healing indices at 1, 7, and 15 days post-surgery. The primary objective is to determine if the microRepair ABX technology enhances tissue regeneration and reduces post-operative complications.
Eligibility criteria
Qualifiers
Destructive caries that do not allow for conservative or prosthetic recovery.
Untreatable endodontic and/or periapical lesions.
Advanced periodontal lesions with significant loss of supporting tissue.
Traumatic lesions involving root fractures (vertical or at the middle third).
Disqualifiers
None
Trial design
Treatments tested in this trial
- microRepair ABX Mousse
- CHX mouthwash 0.20%
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov